Marx S - Search Results

1

New anticoagulants - promising and failed developments.

Harenberg J, Marx S, Krejczy M, Wehling M. Harenberg J, et al. Among authors: marx s. Br J Pharmacol. 2012 Jan;165(2):363-72. doi: 10.1111/j.1476-5381.2011.01578.x. Br J Pharmacol. 2012. PMID: 21740405 Free PMC article. Review.

2

Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability.

Harenberg J, Krämer R, Giese C, Marx S, Weiss C, Wehling M. Harenberg J, et al. Among authors: marx s. J Thromb Thrombolysis. 2011 Oct;32(3):267-71. doi: 10.1007/s11239-011-0622-5. J Thromb Thrombolysis. 2011. PMID: 21811937 Free PMC article.

3

Determination of the anticoagulant effects of new oral anticoagulants: an unmet need.

Harenberg J, Marx S, Erdle S, Krämer R. Harenberg J, et al. Among authors: marx s. Expert Rev Hematol. 2012 Feb;5(1):107-13. doi: 10.1586/ehm.11.79. Expert Rev Hematol. 2012. PMID: 22272710 Review.

4

Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.

Harenberg J, Marx S, Dahl OE, Marder VJ, Schulze A, Wehling M, Weiss C. Harenberg J, et al. Among authors: marx s. Thromb Haemost. 2012 Nov;108(5):903-12. doi: 10.1160/TH12-07-0482. Epub 2012 Sep 26. Thromb Haemost. 2012. PMID: 23014668

5

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.

Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C. Harenberg J, et al. Among authors: marx s. Int Angiol. 2012 Aug;31(4):330-9. Int Angiol. 2012. PMID: 22801398 Review.

6

Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban.

Harenberg J, Marx S, Krämer R, Giese C, Weiss C. Harenberg J, et al. Among authors: marx s. Blood Coagul Fibrinolysis. 2011 Dec;22(8):637-41. doi: 10.1097/MBC.0b013e328349f1d6. Blood Coagul Fibrinolysis. 2011. PMID: 21986465

7

Determination of dabigatran in human plasma samples.

Harenberg J, Giese C, Marx S, Krämer R. Harenberg J, et al. Among authors: marx s. Semin Thromb Hemost. 2012 Feb;38(1):16-22. doi: 10.1055/s-0031-1300947. Epub 2012 Feb 7. Semin Thromb Hemost. 2012. PMID: 22314599 Review.

8

Determination of rivaroxaban in human plasma samples.

Harenberg J, Erdle S, Marx S, Krämer R. Harenberg J, et al. Among authors: marx s. Semin Thromb Hemost. 2012 Mar;38(2):178-84. doi: 10.1055/s-0032-1301415. Epub 2012 Feb 17. Semin Thromb Hemost. 2012. PMID: 22422332

9

Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries.

Krejczy M, Harenberg J, Marx S, Obermann K, Frölich L, Wehling M. Krejczy M, et al. Among authors: marx s. J Thromb Thrombolysis. 2014 May;37(4):507-23. doi: 10.1007/s11239-013-0989-6. J Thromb Thrombolysis. 2014. PMID: 24221805

10

Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.

Harenberg J, Marx S, Weiss C, Krämer R, Samama M, Schulman S; Subcommittee on Control of Anticoagulation of the ISTH. Harenberg J, et al. Among authors: marx s. J Thromb Haemost. 2012 Jul;10(7):1433-6. doi: 10.1111/j.1538-7836.2012.04784.x. J Thromb Haemost. 2012. PMID: 22947062 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters